PTP4A3 and neoplasm: As our results here demonstrate that PRL3 is a broad, tumor-associated target expressed in an average of 80.6% of human tumors across 11 varied tumor types (Table 1), a question that remained was whether PRL3+ human tumors, like mouse tumors (Fig. 2f), also express surface PRL3.